MMP9 and meningioma: Several immunohistochemical parameters including Ki-67/ MIB-1, MMP-9, PR, ER are used as an adjunct to the histopathological grading to predict the meningioma prognosis.[4,10–13] Similarly, several radiological features are used in conjunction with histopathological grading to identify benign versus aggressive meningioma features.